264. Immune Gene-Therapy of Cancer Using Redirected Naïve or Effector Lymphocytes
264. Immune Gene-Therapy of Cancer Using Redirected Naïve or Effector Lymphocytes
About this item
Full title
Author / Creator
Publisher
Milwaukee: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
Milwaukee: Elsevier Limited
Subjects
More information
Scope and Contents
Contents
In order to expand the recognition spectrum of effector lymphocytes and redirect them in non-individual restricted manner to predefined targets, we have developed the 'T-body' approach for adoptive cancer immunotherapy, using chimeric receptor genes with antibody-type specificity. The modular structure of the chimeric receptor containing ecto-, scF...
Alternative Titles
Full title
264. Immune Gene-Therapy of Cancer Using Redirected Naïve or Effector Lymphocytes
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1792804799
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1792804799
Other Identifiers
ISSN
1525-0016
E-ISSN
1525-0024
DOI
10.1016/j.ymthe.2006.08.318
